Global Filters




Tiers


Species


Attribution

Filter by Tier
Filter by Species
Filter by Attributions
like "mouse, Ap3m2, alcohol"

Returning 84 results: Page 1 of 4


Tier Species Size Attr. GeneSet
Tier IV 3151 GS3647: Meta-analysis of brain gene expression associated with voluntary consumption of ethanol in mice
Tier I 10720 GS125506: Valproic Acid interacting with Homo sapiens associated genes (MeSH:D014635) in CTD
Tier III 3625 GS218390: Alcoholism Susceptibility Chr 1
Tier I 312 GS270774: GWAS Catalog Data for body mass index in up to 104,666 European ancestry male individuals, up to 132,115 European ancestry female individuals, 370 African American male individuals, 517 African American female individuals, 512 Hispanic male individuals, 764 Hispanic female individuals
Tier IV 809 GS380589: Down regulated genes in host transcriptional response to IAV in human adenocarcinomic alveolar basal epithelial (A549) cells
Tier III 1172 GS400142: Differentially expressed genes in the ventral tegmental area of mice given acute cocaine vs acute saline (RNA-seq) - linear regression (LR)
Tier III 216 GS400391: THC suppressed genes in mouse CD4 cells (>=2 fold) (RNA-seq)
Tier IV 18653 GS407376: Dysregulation of NRSF/REST via EHMT1 is associated with psychiatric disorders and Kleefstra syndrome
Tier III 17260 GS407755: Microglial-specific transcriptome changes following chronic alcohol consumption in mice log2FC
Tier III 19712 GS407757: Microglial-specific transcriptome changes following chronic alcohol consumption in mice total homogenate log2FC
Tier III 19712 GS407758: Microglial-specific transcriptome changes following chronic alcohol consumption in mice total homogenate p-value
Tier III 19901 GS407933: Differentially expressed genes of post mortem human central Amygdala samples in patients affected by opioid use disorder (OUD) vs. unaffected control samples_Log2FC
Tier III 19901 GS407934: Differentially expressed genes of post mortem human central Amygdala samples in patients affected by opioid use disorder (OUD) vs. unaffected control samples_qvalue
Tier III 1918 GS407940: Differentially expressed genes of ventral midbrain in humans with chronic opioid use disorder in microglia
Tier III 17086 GS407944: Differentially expressed genes in opioid use disorder postmortem human brain_qvalue
Tier III 17086 GS407945: Differentially expressed genes in opioid use disorder postmortem human brain_log2FC
Tier III 18513 GS407948: Differentially expressed genes in humans nucleus accumbens associated with opioid use disorder_log2FC
Tier III 18278 GS407950: Differentially expressed genes in humans dorsolateral prefrontal cortex associated with opioid use disorder_log2FC
Tier III 18278 GS407951: Differentially expressed genes in humans dorsolateral prefrontal cortex associated with opioid use disorder_qvalue
Tier III 19863 GS407964: Differential gene expression in human postmortem tissue samples of the dorsolateral prefrontal cortex_logFC
Tier III 19863 GS407965: Differential gene expression in human postmortem tissue samples of the dorsolateral prefrontal cortex_qvalue
Tier IV 9363 GS408182: Differential gene expression comparison between Carnegie Stages (CS) 15 and 22 during human embryo craniofacial development, log2FC
Tier IV 9363 GS408183: Differential gene expression comparison between Carnegie Stages (CS) 15 and 22 during human embryo craniofacial development, Adj-P value
Tier IV 10391 GS408184: Differential gene expression comparison between Carnegie Stages (CS) 13 and 22 during human embryo craniofacial development, log2FC
Tier IV 10391 GS408185: Differential gene expression comparison between Carnegie Stages (CS) 13 and 22 during human embryo craniofacial development, Adj-P value